Among the genes significantly affected by all three ERG fusions (Fig. 1C), we noted the up-regulation of PIM1, an oncogene whose expression is increased in tumors from both haematological and epithelial origin, including prostate cancer [22], [32], [33]. Here, ERG is linked to prostate cancer.